Brenda Sandmaier
Professor
Medicine
Fred Hutchinson Cancer Rearch Center
United States of America
Biography
Dr. Sandmaier is a UW professor of medicine in the Division of Oncology and member in the Clinical Research Division at the Fred Hutchinson Cancer Research Center. Dr. Sandmaier earned her B.S. and her M.D. at the University of Alberta, Canada. After completing her internship and residency in internal medicine at Kaiser Santa Clara, CA, she came to UW to do her fellowship in medical oncology. Upon completion of her fellowship, she became a faculty member at Fred Hutchinson Cancer Research Center and the UW.
Research Interest
Reduced intensity conditioning for allogeneic hematopoietic cell transplantation, use of alternative donors, radioimmunotherapy for use as conditioning prior to allogeneic hematopoietic cell transplantation and prevention of graft versus host disease after transplant.
Publications
-
Cassaday RD, Alan Potts D, Stevenson PA, Bar M, Georges GE, Shustov AR, Sorror ML, Wood BL, Delaney C, Doney KC et al.. 2016. Evaluation of allogeneic transplantation in first or later minimal residual disease - negative remission following adult-inspired therapy for acute lymphoblastic leukemia.. Leukemia & lymphoma. :1-10.
-
Storb R, Sandmaier BM. 2016. Nonmyeloablative allogeneic hematopoietic cell transplantation.. Haematologica. 101(5):521-30
-
Aki SZ, Inamoto Y, Carpenter PA, Storer BE, Sandmaier BM, Lee SJ, Martin PJ, Flowers MED. 2016. Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity.. Bone marrow transplantation. 51(10):1350-1353.
-
Milano F, Gooley T, Wood B, Woolfrey A, Flowers ME, Doney K, Witherspoon R, Mielcarek M, Deeg HJ, Sorror M et al.. 2016. Cord-Blood Transplantation in Patients with Minimal Residual Disease.. The New England journal of medicine. 375(10):944-53.
